# Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

> **NCT00004748** · PHASE3 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 90 (—)

## Conditions studied

- Liver Cirrhosis, Biliary

## Interventions

- **DRUG:** colchicine
- **DRUG:** methotrexate
- **DRUG:** ursodiol

## Key facts

- **NCT ID:** NCT00004748
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 90 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004748, "Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00004748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*